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Cardiac arrhythmias are associated with a wide range of clinical
problems, ranging from relatively benign (a)symptomatic heart
rhythm alterations to life-threatening ventricular arrhythmias
associated with sudden cardiac death. In most cases, atrial and
ventricular arrhythmias are acquired, i.e., secondary to cardiac
(structural) pathologies, including valvular disease, heart failure,
cardiomyopathy, coronary artery disease, and myocardial infarc-
tion. Mechanisms underlying arrhythmogenesis in these condi-
tions have been extensively investigated in the last decades (Janse,
2004; Rubart and Zipes, 2005). In a subset of patients, however,
cardiac arrhythmias occur secondary to congenital or inherited
alterations in electrophysiological properties of cardiomyocytes.
Cardiac arrhythmias secondary to hereditary genetic disorders
are increasingly recognized as a cause for sudden cardiac death
in the general population (Perrin and Gollob, 2013). Mutations
in a large number of genes encoding either ion channels, pro-
teins involved in cell–cell coupling, or other proteins directly or
indirectly influencing cardiac electrophysiology have been iden-
tified in affected patients (Amin et al., 2010; George, 2013).
Widespread genetic testing has in some cases allowed for devel-
opment of genotype-specific treatment strategies (Hofman et al.,
2010; Ackerman et al., 2011). However, in-depth studies of the
mechanisms underlying the observed electrophysiological abnor-
malities are often limited in patients, and in vitro studies in
heterologous expression systems may not adequately reflect the
endogenous cardiomyocyte environment. As reviewed in this
Research Topic of Frontiers in Cardiac Electrophysiology, trans-
genic mouse models incorporating the genetic defect in question
may be successful in studying genotype-phenotype correlations
and may provide important insight into the underlying electro-
physiological, biophysical, and molecular mechanisms.
The availability of genetically engineered transgenic mice
has allowed for detailed investigation of the in vivo, ex vivo,
and in vitro electrophysiological consequences of human muta-
tions associated with arrhythmias. However, as reviewed by
Kaese and Verheule, certain cardiac electrophysiological proper-
ties are inherently different between mouse and man (Kaese and
Verheule, 2012). The authors conclude that transgenic mouse
models may nevertheless successfully mimic human arrhythmia
syndromes although observations regarding arrhythmia mech-
anisms may only be extrapolated to the human situation with
caution. Grubb and co-workers provide an overview of studies
on mice deficient for the potassium channel interacting pro-
tein KChIP2, a component of the transient outward potassium
current (Ito) (Grubb et al., 2012). These studies have provided
increased insight into the multiple actions of this promiscuous
accessory protein, andKChIP2 is now known tomodulate numer-
ous potassium channels in addition to L-type calcium channels
and possibly sodium channels (Grubb et al., 2012). The cardiac
conduction system is another area where genetic defects in ion
channels have been associated with arrhythmias and sudden car-
diac death. Hyperpolarization-activated Cyclic Nucleotide-gated
(HCN) channels, which are responsible for the pacemaker funny
current If, are located specifically within the conduction sys-
tem. A range of transgenic mouse models of different HCN
isoforms has shed light on the role of If on pacemaking and atrio-
ventricular conduction, as reviewed by Bucchi et al. (2012) and
Aránega et al. (2012). In other models, genetic defects in certain
ion channels widely expressed throughout the myocardium were
found to have specific electrophysiological consequences within
the specialized conduction system, which may promote arrhyth-
mias (Aránega et al., 2012). In particular, mice with genetic
alterations in the Scn5a gene encoding the cardiac sodium chan-
nel have provided insight into the role of this channel in both
sinus node dysfunction and progressive cardiac conduction dis-
ease, as detailed by Huang et al. (2012). The various available
Scn5a transgenic mouse models (in addition to mice lacking spe-
cific sodium channel auxillary β-subunits) have furthermore been
instrumental in clarifying the biophysical alterations underly-
ing Long QT syndrome type 3, Brugada syndrome, and cardiac
conduction disease, inherited conditions associated with sodium
channel mutations (Derangeon et al., 2012). Transgenic mice
also allow for in-depth investigation of the interaction between
(abnormalities in) cardiogenesis and arrhythmias. This is exem-
plified by Franco and colleagues who review the role for the
transcription factor PITX2 in cardiac (in particular pulmonary
vein) development and its link with atrial arrhythmias including
atrial fibrillation (Franco et al., 2012). The many existing mouse
models of atrial fibrillation and their usefulness for studying the
pathways andmechanisms underlying this complex arrhythmia is
further discussed by Riley et al. (2012). Defects in cytoskeletal sig-
naling pathways have also been associated with atrial fibrillation,
as shown by studies in mice with a heterozygous deficiency for
the adapter protein Ankyrin-B (Smith et al., 2012). Ankyrin-B+/−
mice have further provided fundamental insight into the role
of ankyrins in sinus node disease and ventricular arrhyth-
mias (Smith et al., 2012). Finally, the use of murine transgenic
and targeted models of desmosomal proteins associated with
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arrhythmogenic right ventricular cardiomyopathy (ARVC) has
been instrumental in investigating disease etiology and progres-
sion in addition to the complex interaction between cell adhesion
defects and arrhythmogenesis in this inherited syndrome (Lodder
and Rizzo, 2012).
Apart from transgenic mouse models, novel techniques are
increasingly recognized as useful in studying electrical roles of
novel identified genes, and electrophysiological effects of specific
mutations in the native cardiomyocyte environment. Zebrafish
(Danio rerio) are relatively easy to study and genetically modify,
but crucial differences exist between zebrafish and human cardiac
electrophysiology (Verkerk and Remme, 2012). Nevertheless, ion
channel disorders related to repolarization disorders have been
successfully modeled in zebrafish; their applicability in study-
ing depolarization disorders and calcium-related arrhythmias
is however as yet unclear (Verkerk and Remme, 2012). More
recently, it has been shown that human-induced pluripotent stem
cell-derived (iPSC) cardiomyocytes may recapitulate disease phe-
notype in Mendelian cardiac rhythm disorders (Hoekstra et al.,
2012). Although the interpretation of electrophysiological data
from iPSC-derived cardiomyocytes should be done with caution
(due to their immature phenotype), they are considered a promis-
ing tool for studying pathophysiology, genotype-phenotype rela-
tionship, and pharmacology in cardiac arrhythmia syndromes
(Hoekstra et al., 2012).
In summary, the collection of 12 articles presented in this
Research Topic provides an overview of the knowledge and insight
obtained from various transgenic and targeted models of cardiac
electrophysiology, and how further research in this field may be of
additional benefit for the future identification, risk-stratification,
and treatment of patients with inherited cardiac arrhythmias and
sudden death.
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